These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 38634344)

  • 1. Neutrophil antigen antibodies affect engraftment and secondary graft failure in hematopoietic progenitor cell transplantation.
    Alswied A; Hassan S; Rai H; Flegel WA
    Transfusion; 2024 Jun; 64(6):1050-1058. PubMed ID: 38634344
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Factors predicting haematopoietic recovery in patients undergoing autologous transplantation: 11-year experience from a single centre.
    Bai L; Xia W; Wong K; Reid C; Ward C; Greenwood M
    Ann Hematol; 2014 Oct; 93(10):1655-64. PubMed ID: 24870941
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Donor-Specific HLA Antibodies Are Associated with Graft Failure and Delayed Hematologic Recovery after Unrelated Donor Hematopoietic Cell Transplantation.
    Lima ACM; Getz J; do Amaral GB; Loth G; Funke VAM; Nabhan SK; Petterle RR; de Marco R; Gerbase-DeLima M; Pereira NF; Bonfim C; Pasquini R
    Transplant Cell Ther; 2023 Aug; 29(8):493.e1-493.e10. PubMed ID: 37220839
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hematopoietic stem cell transplantation using single UM171-expanded cord blood: a single-arm, phase 1-2 safety and feasibility study.
    Cohen S; Roy J; Lachance S; Delisle JS; Marinier A; Busque L; Roy DC; Barabé F; Ahmad I; Bambace N; Bernard L; Kiss T; Bouchard P; Caudrelier P; Landais S; Larochelle F; Chagraoui J; Lehnertz B; Corneau S; Tomellini E; van Kampen JJA; Cornelissen JJ; Dumont-Lagacé M; Tanguay M; Li Q; Lemieux S; Zandstra PW; Sauvageau G
    Lancet Haematol; 2020 Feb; 7(2):e134-e145. PubMed ID: 31704264
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mesenchymal stem cells versus mesenchymal stem cells combined with cord blood for engraftment failure after autologous hematopoietic stem cell transplantation: a pilot prospective, open-label, randomized trial.
    Xiong YY; Fan Q; Huang F; Zhang Y; Wang Y; Chen XY; Fan ZP; Zhou HS; Xiao Y; Xu XJ; Dai M; Xu N; Sun J; Xiang P; Huang XJ; Liu QF
    Biol Blood Marrow Transplant; 2014 Feb; 20(2):236-42. PubMed ID: 24216182
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Role of HLA Antibodies in HLA Mismatched Allogeneic Hematopoietic Stem Cell Transplantation.
    Zhang X; Wang J; Zhou Z; Zhang Y; Liu H; Tong C; Yu C; Lu Y; Zhao Y; Xiong M; Zhou JR; Juan S; Liu DY; Wei Z; Zhang J; Wu T; Lu DP
    Clin Transpl; 2014; ():245-50. PubMed ID: 26281152
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nonmyeloablative HLA-matched sibling allogeneic hematopoietic stem cell transplantation for severe sickle cell phenotype.
    Hsieh MM; Fitzhugh CD; Weitzel RP; Link ME; Coles WA; Zhao X; Rodgers GP; Powell JD; Tisdale JF
    JAMA; 2014 Jul; 312(1):48-56. PubMed ID: 25058217
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Complement-Binding Donor-Specific Anti-HLA Antibodies and Risk of Primary Graft Failure in Hematopoietic Stem Cell Transplantation.
    Ciurea SO; Thall PF; Milton DR; Barnes TH; Kongtim P; Carmazzi Y; López AA; Yap DY; Popat U; Rondon G; Lichtiger B; Aung F; Afshar-Kharghan V; Ma Q; Fernández-Viña M; Champlin RE; Cao K
    Biol Blood Marrow Transplant; 2015 Aug; 21(8):1392-8. PubMed ID: 25985919
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outcomes with allogeneic stem cell transplant using cryopreserved versus fresh hematopoietic progenitor cell products.
    Wan BA; Lindo L; Mourad YA; Chung S; Forrest D; Kuchenbauer F; Nantel S; Narayanan S; Nevill T; Power M; Rodrigo J; Sanford D; Song K; Stubbins RJ; Sutherland H; Toze CL; White J; Roy C; Hay KA
    Cytotherapy; 2024 Oct; 26(10):1210-1216. PubMed ID: 38819367
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Positive Cytotoxic Crossmatch Predicts Delayed Neutrophil Engraftment in Allogeneic Hematopoietic Cell Transplantation from HLA-Mismatched Related Donors.
    Kameda K; Nakasone H; Komiya Y; Kanda J; Gomyo A; Hayakawa J; Akahoshi Y; Tamaki M; Harada N; Kusuda M; Ugai T; Ishihara Y; Kawamura K; Sakamoto K; Sato M; Tanihara A; Wada H; Terasako-Saito K; Kikuchi M; Kimura SI; Kako S; Kanda Y
    Biol Blood Marrow Transplant; 2017 Nov; 23(11):1895-1902. PubMed ID: 28684373
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The impact of donor-to-recipient gender compatibility on outcomes of haploid hematopoietic stem cell transplantation in patients with hematological malignancies].
    Hu SS; Wu YB; Zhu PP; Shi JM; Yu J; Zhao YM; Lai XY; Liu LZ; Fu HR; Huang H; Luo Y
    Zhonghua Xue Ye Xue Za Zhi; 2022 Dec; 43(12):992-1002. PubMed ID: 36709104
    [No Abstract]   [Full Text] [Related]  

  • 12. Monthly prospective analysis of hematopoietic chimerism after allogeneic hematopoietic cell transplantation.
    Lee KH; Lee JH; Choi SJ; Lee JH; Kim S; Seol M; Lee YS; Kim WK; Kwon MR; Choi SJ; Park CJ; Chi HS; Lee JS
    Bone Marrow Transplant; 2003 Aug; 32(4):423-31. PubMed ID: 12900780
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of hematopoietic chimerism at day +14 on engraftment after unrelated donor umbilical cord blood transplantation for hematologic malignancies.
    Moscardó F; Sanz J; Senent L; Cantero S; de la Rubia J; Montesinos P; Planelles D; Lorenzo I; Cervera J; Palau J; Sanz MA; Sanz GF
    Haematologica; 2009 Jun; 94(6):827-32. PubMed ID: 19483157
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Graft Failure Incidence, Risk Factors, and Outcomes in Patients Undergoing Non-Myeloablative Allogeneic Hematopoietic Cell Transplantation Using Post-Transplant Cyclophosphamide.
    Mata JR; Zahurak M; Rosen N; DeZern AE; Jones RJ; Ambinder AJ
    Transplant Cell Ther; 2024 Jun; 30(6):588-596. PubMed ID: 38521411
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plerixafor (a CXCR4 antagonist) following myeloablative allogeneic hematopoietic stem cell transplantation enhances hematopoietic recovery.
    Green MM; Chao N; Chhabra S; Corbet K; Gasparetto C; Horwitz A; Li Z; Venkata JK; Long G; Mims A; Rizzieri D; Sarantopoulos S; Stuart R; Sung AD; Sullivan KM; Costa L; Horwitz M; Kang Y
    J Hematol Oncol; 2016 Aug; 9(1):71. PubMed ID: 27535663
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Importance of day 21 BM chimerism in sustained neutrophil engraftment following double-unit cord blood transplantation.
    Avery S; Voss MH; Gonzales AM; Lubin M; Castro-Malaspina H; Giralt S; Kernan NA; Scaradavou A; Hedvat CV; Stevens CE; Barker JN
    Bone Marrow Transplant; 2012 Aug; 47(8):1056-60. PubMed ID: 22139066
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Standardizing Definitions of Hematopoietic Recovery, Graft Rejection, Graft Failure, Poor Graft Function, and Donor Chimerism in Allogeneic Hematopoietic Cell Transplantation: A Report on Behalf of the American Society for Transplantation and Cellular Therapy.
    Kharfan-Dabaja MA; Kumar A; Ayala E; Aljurf M; Nishihori T; Marsh R; Burroughs LM; Majhail N; Al-Homsi AS; Al-Kadhimi ZS; Bar M; Bertaina A; Boelens JJ; Champlin R; Chaudhury S; DeFilipp Z; Dholaria B; El-Jawahri A; Fanning S; Fraint E; Gergis U; Giralt S; Hamilton BK; Hashmi SK; Horn B; Inamoto Y; Jacobsohn DA; Jain T; Johnston L; Kanate AS; Kansagra A; Kassim A; Kean LS; Kitko CL; Knight-Perry J; Kurtzberg J; Liu H; MacMillan ML; Mahmoudjafari Z; Mielcarek M; Mohty M; Nagler A; Nemecek E; Olson TS; Oran B; Perales MA; Prockop SE; Pulsipher MA; Pusic I; Riches ML; Rodriguez C; Romee R; Rondon G; Saad A; Shah N; Shaw PJ; Shenoy S; Sierra J; Talano J; Verneris MR; Veys P; Wagner JE; Savani BN; Hamadani M; Carpenter PA
    Transplant Cell Ther; 2021 Aug; 27(8):642-649. PubMed ID: 34304802
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combination treatment of rituximab and donor platelets infusion to reduce donor-specific anti-HLA antibodies for stem cells engraftment in haploidentical transplantation.
    Zhang R; He Y; Yang D; Jiang E; Ma Q; Pang A; Zhai W; Wei J; Feng S; Han M
    J Clin Lab Anal; 2020 Jul; 34(7):e23261. PubMed ID: 32112480
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cryopreservation of Allogeneic Hematopoietic Cell Products During COVID-19 Pandemic: Graft Characterization and Engraftment Outcomes.
    Keyzner A; Azzi J; Jakubowski R; Sinitsyn Y; Tindle S; Shpontak S; Kwon D; Isola L; Iancu-Rubin C
    Transplant Proc; 2023 Oct; 55(8):1799-1809. PubMed ID: 37210273
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Engraftment kinetics and hematopoietic chimerism after reduced-intensity conditioning with fludarabine and treosulfan before allogeneic stem cell transplantation.
    Blau IW; Schmidt-Hieber M; Leschinger N; Göldner H; Knauf W; Hopfenmüller W; Thiel E; Blau O
    Ann Hematol; 2007 Aug; 86(8):583-9. PubMed ID: 17468869
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.